245 related articles for article (PubMed ID: 17043643)
1. Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Carvalho G; Fabre C; Braun T; Grosjean J; Ades L; Agou F; Tasdemir E; Boehrer S; Israel A; Véron M; Fenaux P; Kroemer G
Oncogene; 2007 Apr; 26(16):2299-307. PubMed ID: 17043643
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Fabre C; Carvalho G; Tasdemir E; Braun T; Adès L; Grosjean J; Boehrer S; Métivier D; Souquère S; Pierron G; Fenaux P; Kroemer G
Oncogene; 2007 Jun; 26(28):4071-83. PubMed ID: 17213804
[TBL] [Abstract][Full Text] [Related]
3. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
4. Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB.
Shifera AS
J Cell Physiol; 2010 Jun; 223(3):558-61. PubMed ID: 20301198
[TBL] [Abstract][Full Text] [Related]
5. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Grosjean-Raillard J; Tailler M; Adès L; Perfettini JL; Fabre C; Braun T; De Botton S; Fenaux P; Kroemer G
Oncogene; 2009 Feb; 28(8):1099-109. PubMed ID: 19079347
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO.
Frelin C; Imbert V; Bottero V; Gonthier N; Samraj AK; Schulze-Osthoff K; Auberger P; Courtois G; Peyron JF
Cell Death Differ; 2008 Jan; 15(1):152-60. PubMed ID: 17932497
[TBL] [Abstract][Full Text] [Related]
8. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
[TBL] [Abstract][Full Text] [Related]
10. Proteins that bind to IKKgamma (NEMO) and down-regulate the activation of NF-kappaB.
Shifera AS
Biochem Biophys Res Commun; 2010 Jun; 396(3):585-9. PubMed ID: 20457134
[TBL] [Abstract][Full Text] [Related]
11. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
[TBL] [Abstract][Full Text] [Related]
12. Extending the nuclear roles of IkappaB kinase subunits.
Gloire G; Dejardin E; Piette J
Biochem Pharmacol; 2006 Oct; 72(9):1081-9. PubMed ID: 16846590
[TBL] [Abstract][Full Text] [Related]
13. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site.
Rushe M; Silvian L; Bixler S; Chen LL; Cheung A; Bowes S; Cuervo H; Berkowitz S; Zheng T; Guckian K; Pellegrini M; Lugovskoy A
Structure; 2008 May; 16(5):798-808. PubMed ID: 18462684
[TBL] [Abstract][Full Text] [Related]
14. Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.
Monks NR; Pardee AB
J Cell Biochem; 2006 May; 98(1):221-33. PubMed ID: 16408291
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
[TBL] [Abstract][Full Text] [Related]
16. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
Qin Y; Auh S; Blokh L; Long C; Gagnon I; Hamann KJ
Cell Mol Immunol; 2007 Feb; 4(1):43-52. PubMed ID: 17349210
[TBL] [Abstract][Full Text] [Related]
18. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
19. [Human pathologies associated with NF-kappaB defects].
Courtois G; Israël A
J Soc Biol; 2004; 198(2):93-6. PubMed ID: 15368956
[TBL] [Abstract][Full Text] [Related]
20. Flt3 receptor inhibition reduces constitutive NFkappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Grosjean-Raillard J; Adès L; Boehrer S; Tailler M; Fabre C; Braun T; De Botton S; Israel A; Fenaux P; Kroemer G
Apoptosis; 2008 Sep; 13(9):1148-61. PubMed ID: 18670883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
